606O Initial results from a first-in-human study of the B7-H4-directed antibody-drug conjugate (ADC) AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors

Funda Meric‐Bernstam, Yoichi Naito, Stéphanie Gaillard, T. Shimoi, Vincent Chung, Andrew A. Davis, Theresa A. Proia, Amal Ayyoub, Manjusha Kulkarni, Sameer Upadhyay, Neil R. Miller, Nadia Luheshi, Andreea Varga, D-Y. Oh, Linda Mileshkin